Celebrating faculty and staff achievements, and other notable news
Dec. 18, 2015
| By Fred Hutch News Service staff
Fred Hutch bone marrow transplant program at Seattle Cancer Care Alliance receives top recognition for third consecutive year; St. Louis Cardinals pitcher Adam Wainwright named 51st Hutch Award winner; Uganda's minister of health visits Fred Hutch; Fred Hutch Global Oncology hosts toy drive for kids with cancer in Uganda; Dr. Oliver Press edits hematology textbook.
John Pagel’s research offers hope with novel treatment combination for older patients
Nov. 9, 2009
| By Dean Forbes
For the first time, Fred Hutchinson Cancer Research Center Clinical Research Division investigators used a radiolabeled antibody to deliver targeted doses of radiation, followed by a stem cell transplant, to successfully treat a group of leukemia and pre-leukemia patients for whom there previously had been no other curative treatment options. Results of the study, led by Dr. John Pagel, appeared online Sept. 28 in the journal Blood.
Fred Hutch is proud to be an Equal Opportunity and VEVRAA Employer. We are committed to cultivating a workplace in which diverse perspectives and experiences are welcomed and respected. We do not discriminate on the basis of race, color, religion, creed, ancestry, national origin, sex, age, disability, marital or veteran status, sexual orientation, gender identity, political ideology, or membership in any other legally protected class. We are an Affirmative Action employer. We encourage individuals with diverse backgrounds to apply and desire priority referrals of protected veterans. Read the EEO is the Law poster here.